Asosiy kontentga oʻtish
Sharh maqola

Financial Toxicity and Healthcare Inequities among Oncology Patients in Low- and Middle-Income Countries: A Systematic Review

Makhliyokhon KuldashevaDepartment of Public Health and Healthcare Management No. 1, Tashkent State Medical University, Tashkent, UzbekistanKalash DwivediDepartment of Neurology and Medical Psychology, Tashkent State Medical University, Tashkent, UzbekistanNilufar T. KhamzayevaDepartment of Epidemiology, Tashkent State Medical University, Tashkent, UzbekistanMunira J. AllaevaDepartment of Pharmacology, Tashkent State Medical University, Tashkent, UzbekistanJasurbek A. KholmatovDepartment of Pharmacology, Tashkent State Medical University, Tashkent, UzbekistanNilufar H. GaniyevaDepartment of Forensic Medicine, Tashkent State Medical University, Tashkent, UzbekistanMunirakhon A. MamadjonovaDepartment of Pharmacology, Tashkent State Medical University, Tashkent, UzbekistanMakhliyo A. AlisherovaDepartment of Medical Radiology No. 1, Tashkent State Medical University, Tashkent, UzbekistanIroda B. TakhirovaDepartment of Pharmacology, Tashkent State Medical University, Tashkent, UzbekistanDaler R. OrifzhonovDepartment of Public Health and Healthcare Management No. 1, Tashkent State Medical University, Tashkent, UzbekistanSardor A.o. DursunovDepartment of Pedagogy and Psychology, Tashkent State Medical University, Tashkent, Uzbekistan
2026en
Ochiq kirishOlmos

Litsenziya: cc-by

ABI

Annotatsiya

Abstract Financial toxicity represents a major driver of healthcare inequities among oncology patients in low- and middle-income countries (LMICs). This systematic review found that high out-of-pocket healthcare expenditure frequently resulted in catastrophic financial burden, with prevalence estimates ranging from 48.0 to 96.9%, particularly in South Asia and Sub-Saharan Africa. Low household income, inadequate insurance coverage, rural residence, and reliance on private-sector healthcare were consistently associated with greater financial hardship. Beyond economic consequences, financial toxicity was strongly linked to treatment interruption, delayed healthcare utilization, psychological distress, food insecurity, reduced quality of life, and poorer clinical outcomes. Although public insurance schemes provided partial financial protection in certain settings, substantial out-of-pocket expenditure persisted across most healthcare systems. Overall, these findings underscore the urgent need for equitable health financing reforms, strengthened social protection mechanisms, and universal health coverage strategies to reduce financial toxicity and improve cancer care access in LMICs.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar